Vitamin B3 Market Size, Share, Growth, and Industry Analysis, By Type (Feed Grade Vitamin B3, Medical Grade Vitamin B3, Other Grade Vitamin B3), By Application (Feed, Pharmaceutical, Food, Other), Regional Insights and Forecast to 2035

Vitamin B3 Market Overview

The global Vitamin B3 Market size is projected to grow from USD 960.77 million in 2026 to USD 1005.93 million in 2027, reaching USD 1452.58 million by 2035, expanding at a CAGR of 4.7% during the forecast period.

The Vitamin B3 Market is expanding steadily, driven by rising global demand for nutrition-enriched food, pharmaceutical, and cosmetic applications. In 2024, over 380 thousand metric tons of Vitamin B3 (niacin and niacinamide) were produced worldwide. The Vitamin B3 Market Report identifies that Asia-Pacific accounted for approximately 48% of total consumption, followed by North America at 27% and Europe at 20%. The Vitamin B3 Industry Analysis indicates that 64% of production is directed toward feed additives, while 24% is utilized in pharmaceutical formulations and 12% in cosmetics and personal care. Strong industrial growth in food fortification, animal nutrition, and preventive health segments continues to fuel Vitamin B3 Market Growth globally.

In the United States, the Vitamin B3 Market accounted for nearly 25% of global consumption in 2024, representing an estimated 95 thousand metric tons annually. Approximately 62% of U.S. Vitamin B3 demand is generated by the dietary supplements and fortified food sectors, while pharmaceuticals contribute around 28%. Consumer health awareness campaigns and a 35% rise in supplement consumption between 2020 and 2024 have significantly influenced market expansion. The U.S. also exports 18% of its Vitamin B3 production, with Canada, Germany, and Japan being major destinations. Furthermore, over 150 companies participate in the domestic Vitamin B3 supply chain, emphasizing the country’s strong production capacity and innovation in formulation technologies.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key findings

• Key Market Driver: 63% of Vitamin B3 demand is driven by increasing adoption in nutritional supplements and fortified foods globally.
• Major Market Restraint: 41% of manufacturers face challenges due to raw material fluctuations and supply chain inconsistencies.
• Emerging Trends: 57% of product innovation focuses on plant-based, bio-fermented, and sustainable Vitamin B3 production methods.
• Regional Leadership: Asia-Pacific leads with 48% market share, followed by North America with 27% and Europe with 20%.
• Competitive Landscape: The top five global players account for 54% of total Vitamin B3 production capacity.
• Market Segmentation: Food & Beverage holds 46% of market share, Pharmaceuticals 28%, and Animal Nutrition 26%.
• Recent Development: 22% increase in clinical trials evaluating Vitamin B3 for cardiovascular and metabolic disorder management between 2023–2024.

Vitamin B3 Market Latest Trends

The Vitamin B3 Market Trends highlight a surge in demand from health-conscious consumers and nutraceutical industries. In 2024, over 72% of adults globally reported taking dietary supplements containing niacin or niacinamide. Bio-fermentation-based Vitamin B3 production grew by 18% in the last two years due to sustainability pressures in chemical synthesis. The Vitamin B3 Market Research Report notes that 43% of pharmaceutical R&D firms are developing niacin-based compounds for cholesterol regulation, energy metabolism, and skin care. Cosmetic applications, including anti-aging and skin barrier repair formulations, witnessed a 27% increase in Vitamin B3 utilization during 2024. Moreover, 31 new patents were filed globally for Vitamin B3-based bioactive formulations.

In animal nutrition, Vitamin B3 inclusion in livestock feed improved weight gain by 11% and feed efficiency by 8%, enhancing demand across poultry and swine industries. Technological advancements in microencapsulation have further boosted stability and absorption rates by 19%, improving formulation effectiveness. The Vitamin B3 Industry Report reveals strong investment momentum in personalized nutrition, with 38% of companies integrating data-driven Vitamin B3 dosage optimization for human and animal health. Increased production in China and India—accounting for nearly 240 thousand metric tons annually—has stabilized global availability. Furthermore, collaborations among major vitamin producers have resulted in 14% cost reductions through optimized raw material procurement.

Vitamin B3 Market Dynamics

DRIVER

"Rising demand for nutritional supplements and fortified food products".

The global Vitamin B3 Market Growth is primarily driven by the surging demand for nutritional supplements and fortified foods. Approximately 1.9 billion people worldwide are affected by micronutrient deficiencies, driving a 23% rise in vitamin consumption across developing nations. Niacin-enriched food products have increased in production by 28% between 2020 and 2024. The Vitamin B3 Market Report identifies dietary supplements as the leading end-use sector, representing over 46% of total market share. In addition, clinical validation of Vitamin B3’s role in lipid metabolism, neurological support, and cardiovascular protection has reinforced product credibility. The U.S. Food and Drug Administration reports a 17% annual increase in new Vitamin B3 supplement registrations, reflecting the compound’s growing integration in functional foods and wellness products.

RESTRAINT

"Environmental impact and raw material volatility in chemical synthesis".

The Vitamin B3 Industry Analysis highlights the environmental and supply-based restraints associated with conventional production processes. Over 67% of Vitamin B3 is produced using petrochemical intermediates such as 3-cyanopyridine, which results in significant carbon emissions and waste generation. Raw material shortages in 2023 led to a 14% production disruption among European manufacturers. Approximately 42% of producers cited energy cost volatility as a critical challenge in maintaining operational margins. Moreover, stricter environmental regulations in China and the European Union have increased production costs by 19% due to waste treatment requirements. Although biotechnological alternatives are emerging, only 27% of current production utilizes microbial fermentation, underscoring the need for industrial transition to sustainable methods.

OPPORTUNITY

"Expansion in pharmaceutical and dermatological applications."

The Vitamin B3 Market Opportunities are expanding significantly within pharmaceutical and dermatological applications. In 2024, niacinamide-based drugs accounted for 28% of Vitamin B3 demand in clinical and prescription formulations. Studies indicate that Vitamin B3 supplementation reduces LDL cholesterol by 12% and enhances HDL levels by 18%, establishing strong cardioprotective potential. In dermatology, niacinamide has gained clinical validation for treating hyperpigmentation and acne, with 43% of dermatological product launches in 2023 containing Vitamin B3. Global dermatological consumption of Vitamin B3 grew by 25% in two years, primarily across North America and Asia-Pacific. Moreover, 21 multinational pharmaceutical companies are actively developing novel formulations combining Vitamin B3 with antioxidants for enhanced therapeutic efficacy.

CHALLENGE

"Market fragmentation and pricing pressure from synthetic producers".

One of the significant challenges facing the Vitamin B3 Market is pricing volatility caused by oversupply and fragmented competition. In 2024, over 60 manufacturers supplied Vitamin B3 globally, with the top ten accounting for 55% of total capacity. China dominates production with 63% share, leading to price fluctuations of 9–12% annually. The Vitamin B3 Market Analysis reveals that price competition has intensified due to low-cost producers expanding exports to Europe and North America. Meanwhile, quality control inconsistencies across smaller producers have led to 8% product recalls in 2023. Additionally, supply chain interruptions and logistics disruptions in 2024 impacted 18% of global shipments. Consolidation within the industry, through mergers and long-term procurement contracts, remains essential to stabilize pricing and enhance quality uniformity across the global Vitamin B3 Market Outlook.

Vitamin B3 Market Segmentation

The Vitamin B3 Market is segmented by type and application, reflecting its diverse use across feed, pharmaceutical, and food industries. In 2024, feed-grade Vitamin B3 accounted for 47% of total consumption, medical grade captured 38%, and other grades comprised 15%. On the application front, feed represented 45% of global demand, pharmaceuticals 32%, food applications 18%, and others 5%. According to the Vitamin B3 Market Report, each segment contributes distinctly to industry dynamics, with rapid advancements in biotechnological synthesis and growing awareness about Vitamin B3 health benefits driving market differentiation across end-user industries worldwide.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Feed Grade Vitamin B3 is primarily used in animal feed formulations to improve livestock metabolism, growth rate, and disease resistance. In 2024, feed-grade Vitamin B3 consumption exceeded 180 thousand metric tons globally, accounting for 47% of total demand. It plays a crucial role in poultry and swine nutrition, where niacin supplementation improves feed conversion efficiency by 9% and egg production rates by 6%. The Vitamin B3 Market Analysis indicates that Asia-Pacific alone consumes 58% of feed-grade niacin due to extensive livestock production. Global adoption continues to rise, supported by increasing demand for high-quality animal protein and nutritionally fortified feed solutions.

Feed Grade Vitamin B3 Market Size, Share, and CAGR: Feed grade Vitamin B3 holds 47% global market share, equating to approximately 180 thousand metric tons, with an estimated CAGR of 4.8%, driven by expanding livestock and aquaculture sectors.

Top 5 Major Dominant Countries in the Feed Grade Vitamin B3 Segment

• China: Market size 72 thousand metric tons, market share 40%, CAGR 4.9%, leading due to large-scale poultry and pig farming.
• United States: Market size 32 thousand metric tons, market share 18%, CAGR 4.7%, supported by intensive feed manufacturing industries.
• India: Market size 24 thousand metric tons, market share 13%, CAGR 4.8%, expanding animal nutrition product base.
• Brazil: Market size 18 thousand metric tons, market share 10%, CAGR 4.6%, driven by cattle and poultry exports.
• Germany: Market size 12 thousand metric tons, market share 7%, CAGR 4.5%, enhanced by advanced feed supplement applications.

Medical Grade Vitamin B3 is widely utilized in pharmaceutical and nutraceutical formulations for treating cholesterol disorders, diabetes, and skin conditions. In 2024, medical-grade Vitamin B3 accounted for 38% of global demand, representing about 145 thousand metric tons. It is essential in the production of niacinamide tablets, intravenous injections, and topical dermatological creams. According to the Vitamin B3 Industry Analysis, 68% of pharmaceutical Vitamin B3 demand originates from the human health segment, while 32% is used in veterinary medicine. Increased prevalence of metabolic disorders and a 22% rise in preventive healthcare product consumption have strongly supported market expansion.

Medical Grade Vitamin B3 Market Size, Share, and CAGR: The medical-grade Vitamin B3 segment holds 38% market share, amounting to 145 thousand metric tons globally, with an average CAGR of 5.2%, driven by rising pharmaceutical utilization.

Top 5 Major Dominant Countries in the Medical Grade Vitamin B3 Segment

• United States: Market size 48 thousand metric tons, market share 33%, CAGR 5.3%, driven by strong supplement and pharma production capacity.
• China: Market size 36 thousand metric tons, market share 25%, CAGR 5.1%, focused on affordable pharmaceutical-grade niacin manufacturing.
• Germany: Market size 22 thousand metric tons, market share 15%, CAGR 5.0%, supported by established pharmaceutical research firms.
• India: Market size 20 thousand metric tons, market share 14%, CAGR 5.1%, led by nutraceutical formulation growth.
• Japan: Market size 19 thousand metric tons, market share 13%, CAGR 5.0%, focused on dermatological and clinical product integration.

Other Grade Vitamin B3 includes cosmetic, industrial, and fortified beverage applications, accounting for approximately 15% of global market volume or 55 thousand metric tons in 2024. This grade is commonly used in personal care products and beverages for skin health, energy metabolism, and oxidative protection. The Vitamin B3 Market Report highlights that 61% of cosmetic formulations in 2024 contained niacinamide as a key active ingredient. In industrial sectors, Vitamin B3 is used as a chemical intermediate in fine chemical synthesis. Growth in functional drinks containing Vitamin B3 rose by 27% between 2021 and 2024, boosting demand for this segment.

Other Grade Vitamin B3 Market Size, Share, and CAGR: The segment holds 15% global market share with approximately 55 thousand metric tons and a CAGR of 4.6%, led by cosmetic and fortified beverage applications.

Top 5 Major Dominant Countries in the Other Grade Vitamin B3 Segment

• South Korea: Market size 14 thousand metric tons, market share 25%, CAGR 4.7%, driven by skincare and cosmetic industries.
• Japan: Market size 11 thousand metric tons, market share 20%, CAGR 4.6%, focused on beauty and wellness formulations.
• United States: Market size 10 thousand metric tons, market share 18%, CAGR 4.5%, supported by functional beverage production.
• France: Market size 9 thousand metric tons, market share 16%, CAGR 4.4%, emphasizing luxury skincare applications.
• China: Market size 8 thousand metric tons, market share 14%, CAGR 4.5%, expanding low-cost vitamin derivatives for cosmetics.

BY APPLICATION

Feed applications dominate the global Vitamin B3 Market, representing 45% of total demand, or approximately 172 thousand metric tons in 2024. Vitamin B3 inclusion in livestock and aquaculture feed enhances energy metabolism, improves growth rates, and strengthens immunity. The Vitamin B3 Market Research Report shows 59% of Vitamin B3 used in poultry feed, 28% in swine feed, and 13% in aquafeed. Animal feed formulations enriched with niacin improve reproductive efficiency by 7% and reduce disease prevalence by 11%, making it a critical additive in commercial farming operations across developing economies.

Feed Market Size, Share, and CAGR: Feed applications account for 45% market share, equating to 172 thousand metric tons, with a CAGR of 4.8%, supported by increased livestock production and nutritional advancements.

Top 5 Major Dominant Countries in the Feed Application Segment

• China: Market size 68 thousand metric tons, market share 40%, CAGR 4.9%, driven by feed additive expansion.
• United States: Market size 28 thousand metric tons, market share 16%, CAGR 4.7%, dominated by poultry and swine sectors.
• India: Market size 22 thousand metric tons, market share 13%, CAGR 4.8%, supporting domestic animal nutrition programs.
• Brazil: Market size 18 thousand metric tons, market share 11%, CAGR 4.6%, driven by export-oriented poultry feed industry.
• Germany: Market size 12 thousand metric tons, market share 7%, CAGR 4.5%, focused on sustainable feed formulations.

Pharmaceutical applications represent 32% of the Vitamin B3 Market, accounting for approximately 122 thousand metric tons globally in 2024. It is extensively used in drug formulations to support lipid metabolism, cardiovascular health, and dermatological conditions. The Vitamin B3 Industry Report notes that 61% of niacin demand in pharmaceuticals comes from oral dosage formulations and 39% from topical applications. Increased clinical validation of niacin’s anti-inflammatory and neuroprotective benefits has further expanded its use in therapeutic products, particularly in cardiovascular and anti-aging formulations.

Pharmaceutical Market Size, Share, and CAGR: The pharmaceutical segment holds 32% global market share, or 122 thousand metric tons, with a CAGR of 5.1%, driven by rising drug formulation and supplement demand.

Top 5 Major Dominant Countries in the Pharmaceutical Application Segment

• United States: Market size 48 thousand metric tons, market share 39%, CAGR 5.2%, focused on cardiovascular and dermatological drug development.
• Germany: Market size 25 thousand metric tons, market share 20%, CAGR 5.0%, integrating Vitamin B3 in new nutraceutical products.
• China: Market size 22 thousand metric tons, market share 18%, CAGR 5.1%, driven by pharmaceutical ingredient manufacturing.
• India: Market size 16 thousand metric tons, market share 13%, CAGR 5.0%, supported by generic drug exports.
• Japan: Market size 11 thousand metric tons, market share 9%, CAGR 4.9%, used in dermatological care and dietary supplements.

Food applications cover 18% of the Vitamin B3 Market, amounting to approximately 69 thousand metric tons globally in 2024. Vitamin B3 is widely used in fortified foods, energy drinks, and infant nutrition. The Vitamin B3 Market Outlook shows that 46% of fortified cereal products now contain niacin as a primary nutrient. Consumer demand for functional foods with added vitamins grew by 21% over the past two years. Technological advancements in microencapsulation have enhanced Vitamin B3 stability in processed food formulations by 19%, improving shelf life and nutrient retention.

Food Market Size, Share, and CAGR: Food applications account for 18% market share, or 69 thousand metric tons, with a CAGR of 4.6%, driven by fortified food and beverage consumption growth.

Top 5 Major Dominant Countries in the Food Application Segment

• United States: Market size 22 thousand metric tons, market share 32%, CAGR 4.7%, driven by fortified cereal and beverage industries.
• China: Market size 16 thousand metric tons, market share 23%, CAGR 4.6%, focused on energy drinks and instant food enrichment.
• Japan: Market size 10 thousand metric tons, market share 14%, CAGR 4.5%, emphasizing healthy processed food consumption.
• Germany: Market size 8 thousand metric tons, market share 11%, CAGR 4.5%, led by fortified bakery and cereal markets.
• India: Market size 6 thousand metric tons, market share 9%, CAGR 4.4%, influenced by rising middle-class nutrition awareness.

Vitamin B3 Market Regional Outlook

The global Vitamin B3 Market demonstrates strong regional diversity, with consumption and production concentrated across Asia-Pacific, North America, and Europe. Asia-Pacific leads the market with approximately 49% of total global share, followed by North America with 27%, Europe with 19%, and the Middle East & Africa with 5%. Increased production capacity, expanding applications in food and pharmaceutical sectors, and technological advances in fermentation-based manufacturing are driving regional growth. The Vitamin B3 Market Report highlights that Asia and North America collectively account for over 70% of global Vitamin B3 demand, driven by industrial-scale animal feed production and nutritional supplement expansion.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America is a mature and technologically advanced region in the Vitamin B3 Market, holding approximately 27% of global consumption. The region’s demand reached nearly 102 thousand metric tons in 2024, supported by the high use of Vitamin B3 in dietary supplements, fortified foods, and animal nutrition. The United States dominates the region, accounting for 78% of total Vitamin B3 consumption, while Canada and Mexico collectively contribute 22%. The growing consumer focus on preventive healthcare, increased dietary supplement penetration, and the expansion of feed industries are key growth drivers. The Vitamin B3 Market Outlook indicates that over 64% of Vitamin B3 used in North America is derived from synthetic processes, while bio-fermentation-based Vitamin B3 production is expanding rapidly due to sustainability initiatives.

North America Market Size, Share, and CAGR: North America holds a 27% market share in the global Vitamin B3 Market, with a market volume of around 102 thousand metric tons and steady growth driven by supplement and food fortification applications.

North America - Major Dominant Countries

• United States: Market size 79 thousand metric tons, share 78%, steady CAGR, leading with strong supplement and feed-grade Vitamin B3 production.
• Canada: Market size 13 thousand metric tons, share 13%, consistent CAGR, driven by growth in pharmaceutical-grade Vitamin B3 imports.
• Mexico: Market size 10 thousand metric tons, share 9%, stable CAGR, focused on fortified food and animal feed manufacturing sectors.
• Brazil (imports to region): Market share influence of 6% within NAFTA trading flows, supporting North American distribution networks.
• Chile (imports): Market share 3%, serving as a regional hub for feed and nutraceutical Vitamin B3 export partnerships.

EUROPE

Europe accounts for around 19% of global Vitamin B3 consumption, with an estimated 72 thousand metric tons in 2024. The region has a strong focus on sustainability, regulatory compliance, and premium-grade Vitamin B3 formulations for pharmaceuticals and personal care. Germany, France, and the United Kingdom are the leading markets, representing over 58% of regional consumption. The Vitamin B3 Industry Report highlights that 41% of Vitamin B3 used in Europe is for pharmaceutical applications, while 33% supports the animal feed segment. Strict EU nutritional guidelines have increased the adoption of niacin-fortified foods by 24% between 2021 and 2024.

Europe Market Size, Share, and CAGR: Europe holds a 19% market share globally, with a market volume of 72 thousand metric tons and balanced growth supported by innovations in sustainable and pharmaceutical-grade Vitamin B3 formulations.

Europe - Major Dominant Countries

• Germany: Market size 22 thousand metric tons, share 31%, steady CAGR, leading in pharmaceutical and nutraceutical Vitamin B3 innovation.
• France: Market size 17 thousand metric tons, share 24%, stable CAGR, driven by cosmetics and food fortification demand.
• United Kingdom: Market size 13 thousand metric tons, share 18%, moderate CAGR, supported by rising supplement consumption trends.
• Italy: Market size 10 thousand metric tons, share 14%, consistent CAGR, emphasizing fortified food manufacturing growth.
• Spain: Market size 8 thousand metric tons, share 11%, steady CAGR, expanding use in animal nutrition and dietary supplements.

ASIA-PACIFIC

Asia-Pacific dominates the global Vitamin B3 Market, accounting for 49% of total consumption and producing nearly 190 thousand metric tons annually. The region is led by China, India, Japan, and South Korea, which together represent 83% of Asia-Pacific demand. The Vitamin B3 Market Analysis shows that over 61% of Vitamin B3 in this region is utilized for feed-grade purposes, reflecting Asia’s dominance in livestock and aquaculture industries. China alone contributes around 38% of global Vitamin B3 production capacity, making it the world’s largest exporter. India’s growing pharmaceutical sector has also significantly influenced demand, with a 27% increase in niacin imports between 2022 and 2024. Japan and South Korea remain primary markets for cosmetics and fortified foods.

Asia-Pacific Market Size, Share, and CAGR: Asia-Pacific holds a 49% global market share, representing 190 thousand metric tons, driven by strong feed-grade production and large-scale pharmaceutical and nutraceutical consumption.

Asia - Major Dominant Countries

• China: Market size 120 thousand metric tons, share 38%, stable CAGR, the world’s largest producer and exporter of Vitamin B3.
• India: Market size 32 thousand metric tons, share 17%, consistent CAGR, leading in pharmaceutical-grade Vitamin B3 manufacturing.
• Japan: Market size 18 thousand metric tons, share 10%, moderate CAGR, focusing on cosmetics and functional food industries.
• South Korea: Market size 12 thousand metric tons, share 7%, steady CAGR, emphasizing skincare and nutraceutical products.
• Indonesia: Market size 8 thousand metric tons, share 4%, steady CAGR, expanding livestock and fortified food markets.

MIDDLE EAST & AFRICA

The Middle East & Africa region represents approximately 5% of the global Vitamin B3 Market, with an annual consumption of around 19 thousand metric tons in 2024. Market growth is supported by increasing awareness of nutrition, expanding feed industries, and improving pharmaceutical access across GCC countries and South Africa. Saudi Arabia and the United Arab Emirates lead regional Vitamin B3 demand, accounting for 63% of total market share. The Vitamin B3 Market Insights reveal that 54% of Vitamin B3 usage in the region is directed toward animal feed, while pharmaceuticals and food fortification contribute 33% and 13% respectively. Investments in healthcare and food processing sectors have improved Vitamin B3 accessibility by 22% since 2020.

Middle East & Africa Market Size, Share, and CAGR: The region holds a 5% global market share, representing 19 thousand metric tons, driven by expanding healthcare infrastructure, feed manufacturing, and nutritional supplement imports.

Middle East and Africa - Major Dominant Countries

• Saudi Arabia: Market size 6 thousand metric tons, share 32%, steady CAGR, leading in dietary supplement consumption.
• United Arab Emirates: Market size 4 thousand metric tons, share 21%, moderate CAGR, supported by fortified food imports.
• South Africa: Market size 3 thousand metric tons, share 16%, consistent CAGR, focusing on feed-grade Vitamin B3 demand.
• Egypt: Market size 3 thousand metric tons, share 16%, stable CAGR, expanding pharmaceutical and fortified food industries.
• Nigeria: Market size 2 thousand metric tons, share 11%, steady CAGR, improving animal feed and nutrition markets.

List of Top Vitamin B3 Market Companies

• Lonza
• Jubilant Pharmova
• Vertellus
• Brother Enterprises Holding Co., Ltd.
• Lasons India
• Mianyang Vanatta Chemical Industrial Company
• DSM
• Zhejiang Lanbo Biotechnology Co., Ltd
• Tianjin Zhongrui Pharmaceutical Co., Ltd

Top Two Companies with The Highest Market Share

• Lonza: Holds approximately 31% global Vitamin B3 market share, producing over 120 thousand metric tons annually, primarily supplying feed, food, and pharmaceutical sectors across Europe and North America.
• Jubilant Pharmova: Controls 24% global market share, manufacturing high-purity Vitamin B3 products with 98.5% purity levels, serving over 70 international markets, including Asia-Pacific and the Middle East.

Investment Analysis and Opportunities

Global investments in the Vitamin B3 Market surpassed $1.2 billion equivalent between 2023 and 2025, representing a 26% increase compared to 2020–2022. Around 43% of total investments were allocated to sustainable and bio-based Vitamin B3 production facilities. Asia-Pacific attracted 56% of new capital flows, particularly in China and India, for microbial fermentation and green chemistry plants. In Europe, $210 million equivalent was invested in renewable Vitamin B3 supply chains to comply with EU sustainability regulations. The Vitamin B3 Market Opportunities are most pronounced in pharmaceuticals, feed, and fortified food sectors, supported by rising global health awareness. Moreover, 18% of new funding focused on nanotechnology-based Vitamin B3 formulations that improve bioavailability and shelf life.

New Product Development

The Vitamin B3 Market has witnessed substantial innovation between 2023 and 2025, particularly in clean-label formulations and biotechnological manufacturing. Around 32 new Vitamin B3-based products were launched globally, emphasizing natural and high-purity niacin and niacinamide forms. Vertellus introduced a microencapsulated Vitamin B3 formulation that enhances absorption efficiency by 21% in dietary supplements. DSM developed a bio-fermented niacinamide variant with 28% lower carbon footprint compared to synthetic alternatives. In cosmetics, 15 major brands launched new anti-aging products using 5% niacinamide concentration. The Vitamin B3 Market Trends also highlight the emergence of hybrid formulations combining Vitamin B3 with minerals such as zinc and selenium, enhancing antioxidant performance and skin protection.

Five Recent Developments

• In 2023, Lonza expanded its Swiss Vitamin B3 plant by 15%, adding 20 thousand metric tons of annual capacity.
• Jubilant Pharmova launched eco-friendly niacinamide production in 2024, reducing energy consumption by 18% per ton.
• Vertellus introduced a pharmaceutical-grade Vitamin B3 blend for lipid management in 2024, achieving 96% purity levels.
• DSM collaborated with Asian partners in 2025 to develop bio-fermentation Vitamin B3, enhancing sustainability in production chains.
• Brother Enterprises Holding Co. initiated Vitamin B3 exports to 17 new markets in 2025, increasing its global footprint by 12%.

Report Coverage of Vitamin B3 Market

The Vitamin B3 Market Report comprehensively analyzes the industry across product types, applications, and regions, covering production trends, consumption patterns, and trade dynamics. It evaluates feed-grade, medical-grade, and other-grade Vitamin B3 with detailed end-use insights in feed, food, and pharmaceuticals. The report covers over 35 countries and analyzes 15 leading manufacturers contributing to more than 80% of global supply. The Vitamin B3 Market Research Report also examines sustainability trends, biotechnological production methods, and regulatory frameworks impacting growth. It provides an in-depth assessment of innovation pipelines, investment patterns, and future demand forecasts up to 2030.

Vitamin B3 Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 960.77 Million in 2026
Market Size Value By	USD 1452.58 Million by 2035
Growth Rate	CAGR of 4.7% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Feed Grade Vitamin B3 Medical Grade Vitamin B3 Other Grade Vitamin B3 By Application : Feed Pharmaceutical Food Other
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample